Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer Artificial intelligence (AI) ...
In this context, the AMBORA randomized trial reported on the impact of an intensified OAT pharmacological care program on improving patient safety outcomes and improving patient-reported satisfaction ...